Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of SRIs on Gonadal Steroid Hormones
NCT00611975Phase 4Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Oct 2005
- Primary completion
- May 2008
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of fluoxetine in major depressive disorder (MDD) (2 arms), sponsored by Weill Cornell Medicine. Primary endpoint: Change in 17-OH Pregnenolone at 2 months. Started Oct 2005; status: completed.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00611975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00611975.